Dr. Mark C. Peterson works at Vertex Pharmaceuticals as a Senior Director in Clinical & Quantitative Pharmacology. Prior to that, he was at Pfizer (9 years), Biogen (2 years) and Amgen (8 years). Dr. Peterson received a Bachelor of Sciences in Pharmacy (1992) and a Doctorate in Pharmaceutical Sciences (2000) from the University of Connecticut. Dr. Peterson has experience in protein, cell and gene therapeutics, with various quantitative methods including quantitative systems pharmacology models (QSP). Over his 25-year career he has applied modeling and simulation-based methods to pre-clinical through registration applications. Recently he has been applying Bayesian methodologies to PKPD and working in cell and gene therapy programs.